相关实验视频

Updated: Jun 26, 2025

Murine Model of CD40-activation of B cells

Murine Model of CD40-activation of B cells

Published on: March 5, 2010

下一代CD40激动剂用于癌症免疫治疗

Hampus Andersson^1,2, Barnabas Nyesiga^1,3, Tova Hermodsson²

¹Alligator Bioscience, Alligator Bioscience AB, Lund, Sweden.

Expert opinion on biological therapy

|May 20, 2024

概括

下一代CD40激动剂通过增强T细胞反应和重塑瘤微环境来改善癌症免疫疗法. 这些新的方法旨在提高疗效和安全性,为患者带来更广泛的益处.

科学领域:

免疫瘤学免疫瘤学
癌症治疗治疗癌症治疗
药物开发药物开发

背景情况:

免疫疗法是有前途的,但需要提高反应率和更广泛的适用性.
针对CD40的疗法可以培养瘤特异性T细胞,并逆转免疫抑制瘤微环境.
临床证据支持CD40抗体与化疗相结合,改善免疫治疗结果.

研究的目的:

审查下一代CD40激动剂超越单个特异性抗体.
探索新的方法来提高CD40激动剂的疗效和安全性.
概述目前对瘤微环境中的CD40表达性免疫细胞的理解.

主要方法:

在免疫瘤学中对CD40向疗法的文献综述.
对基于CD40的免疫疗法组合的新兴临床证据的分析.
综合研究CD40表达免疫细胞的作用.

主要成果:

目前正在开发多种下一代CD40激动剂策略.
重点是最大限度地发挥CD40在瘤微环境重塑和T细胞增强中的双重作用.
了解表达CD40的免疫细胞群对于临床发展至关重要.

结论:

下一代CD40激动剂代表了癌症免疫疗法的前沿.
优化CD40向可以通过增强抗瘤反应显著有利于癌症患者.
对CD40表达免疫细胞的进一步研究将指导有效的临床转化.

关键词:

抗体是一种抗体.CD40 CD40 CD40 CD40 CD40 CD40 CD40 CD40 CD40 CD40 CD40 CD40 呈现抗原的细胞.两种特异性的抗体.免疫瘤学免疫瘤学与瘤相关的抗原.

更多相关视频

Generation of Human CD40-activated B cells

Generation of Human CD40-activated B cells

Published on: October 16, 2009

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...